↓ Skip to main content

Dove Medical Press

Akt/PKB activation and insulin signaling: a novel insulin signaling pathway in the treatment of type 2 diabetes

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, February 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (75th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users
patent
1 patent

Citations

dimensions_citation
247 Dimensions

Readers on

mendeley
389 Mendeley
Title
Akt/PKB activation and insulin signaling: a novel insulin signaling pathway in the treatment of type 2 diabetes
Published in
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, February 2014
DOI 10.2147/dmso.s48260
Pubmed ID
Authors

Richard WA Mackenzie, Bradley T Elliott

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 389 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 2 <1%
Austria 1 <1%
Unknown 386 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 76 20%
Student > Ph. D. Student 74 19%
Student > Master 52 13%
Researcher 33 8%
Student > Doctoral Student 18 5%
Other 52 13%
Unknown 84 22%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 106 27%
Agricultural and Biological Sciences 85 22%
Medicine and Dentistry 31 8%
Pharmacology, Toxicology and Pharmaceutical Science 24 6%
Chemistry 11 3%
Other 38 10%
Unknown 94 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 October 2017.
All research outputs
#7,077,903
of 25,457,297 outputs
Outputs from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#286
of 1,184 outputs
Outputs of similar age
#77,472
of 323,100 outputs
Outputs of similar age from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#6
of 10 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 1,184 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 323,100 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 4 of them.